United States - English - NLM (National Library of Medicine)

alk-abello, inc. - house dust (unii: eyo007vx98) (house dust - unii:eyo007vx98) - house dust 10000 [pnu] in 1 ml - these products are for diagnostic use only. diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. by measuring skin test response, the physician may assess the degree of sensitivity that patients have to the allergens. for extracts standardized in au and bau, see individual directions for use. allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use. patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed warning statement and adverse reactions ). the physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise. patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater

United States - English - NLM (National Library of Medicine)

nelco laboratories, inc. - house dust (unii: eyo007vx98) (house dust - unii:eyo007vx98) - house dust 10000 [pnu] in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bell laboratories, inc. - bromadiolone - bait - bromadiolone coumarin active 0.05 g/kg - household insecticide - agricultural/farm buildings | animal housing | commercial/industrial premises | domestic and/or public area | hospital | mill an - mouse - mus spp. | rat

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - european house dust mite extract, quantity: 6 sq-hdm; american house dust mite extract, quantity: 6 sq-hdm - tablet - excipient ingredients: gelatin; sodium hydroxide; purified water; mannitol - allergic rhinitis acarizax is indicated for the treatment of house dust mite (hdm) allergic rhinitis not well controlled despite use of symptom relieving medication in adults and adolescents (? 12 years). allergic asthma acarizax is indicated for the treatment of hdm allergic asthma not well controlled by inhaled corticosteroids and associated with hdm allergic rhinitis in adults. patients? asthma status should be carefully evaluated before the initiation of treatment.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

perma-guard australia pty ltd - piperonyl butoxide; diatomaceous earth; pyrethrin - dust - piperonyl butoxide benzodioxole active 10.0 g/kg; diatomaceous earth filler active 880.0 g/kg; pyrethrin pyrethroid-pyrethrin active 1.0 g/kg - household insecticide - domestic pest control | garden shed | homestead | houses | outbuildings - ant | cockroach | common housefly | flea | insect | silverfish | argentine ant | ctenocephalides spp. | ground fleas | house fly | large cockroach | pharaoh ant | small cockroach

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - disulfiram, quantity: 200 mg - tablet, effervescent - excipient ingredients: tartaric acid; magnesium stearate; povidone; maize starch; microcrystalline cellulose; sodium bicarbonate; colloidal anhydrous silica; purified talc; polysorbate 20 - antabuse tablets are indicated as a deterrent to alcohol comsumption and as an aid in the overall management of selected chronic alcoholic patients involved in an integrated program of counselling and psychiatry. only alcoholic patients who are motivated to abstain from drinking and who are undergoing supportive psychotherapeutic treatment, ancillary to a total program of rehabilitation, should be selected for antabuse administration.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

robust chemicals p/l - piperonyl butoxide | phenothrin-d | tetramethrin - household insecticide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

robust chemicals p/l - piperonyl butoxide | pyrethrin - household insecticide - domestic and/or public area - flying insect | flies | mosquitoes | moths

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

robust chemicals p/l - piperonyl butoxide | pyrethrin - household insecticide - domestic and/or public area - fly | flying insect | flies | mosquitoes | moths

United States - English - NLM (National Library of Medicine)

antigen laboratories, inc. - house dust (unii: eyo007vx98) (house dust - unii:eyo007vx98) - house dust 0.1 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.